General Information of the Compound
Compound ID |
CP0400174
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-pyridin-2-ylsulfanylethanone
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C33H37N3O3S
|
||||||||||||||||||
Molecular Weight |
555.744
|
||||||||||||||||||
Canonical SMILES |
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=Cc5c(C[C@]34C)cnn5-c3ccccc3)[C@@H]1CC[C@]2(O)C(=O)CSc1ccccn1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C33H37N3O3S/c1-31-17-21-19-35-36(23-8-4-3-5-9-23)26(21)16-22(31)11-12-24-25-13-14-33(39,32(25,2)18-27(37)30(24)31)28(38)20-40-29-10-6-7-15-34-29/h3-10,15-16,19,24-25,27,30,37,39H,11-14,17-18,20H2,1-2H3/t24-,25-,27-,30+,31-,32-,33-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
GOOIASWJYDMUEY-YBWODQSBSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00967, Glucocorticoid receptor
Protein ID: PT00870, Glucocorticoid receptor